Growth Metrics

Dna X (SONM) Cash from Operations (2018 - 2025)

Dna X filings provide 8 years of Cash from Operations readings, the most recent being 2004000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 55.56% to 2004000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 23526000.0, a 177.23% decrease, with the full-year FY2025 number at 23526000.0, down 177.23% from a year prior.
  • Cash from Operations hit 2004000.0 in Q4 2025 for Dna X, up from 7034000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 820000.0 in Q2 2023 to a low of 17564000.0 in Q4 2021.
  • Median Cash from Operations over the past 5 years was 3804500.0 (2023), compared with a mean of 4345000.0.
  • Biggest five-year swings in Cash from Operations: skyrocketed 110.9% in 2022 and later plummeted 5617.86% in 2025.
  • Dna X's Cash from Operations stood at 17564000.0 in 2021, then skyrocketed by 87.34% to 2223000.0 in 2022, then surged by 84.21% to 351000.0 in 2023, then tumbled by 1184.62% to 4509000.0 in 2024, then skyrocketed by 55.56% to 2004000.0 in 2025.
  • The last three reported values for Cash from Operations were 2004000.0 (Q4 2025), 7034000.0 (Q3 2025), and 4882000.0 (Q2 2025) per Business Quant data.